We’re investigating a portfolio of additional ASOs aimed to treating additional pulmonary diseases and conditions, which can be properly addressed and treated by splicing modulation and focused lung delivery . We are utilizing our established algorithm, screening technics, proprietary technology and internal well established bio-assays for ASO lead selection and optimization.
Menu